Novo Nordisk announced it is making the popular weight loss medication available to three telehealth ... weight of almost 8% in people with Type 2 diabetes. ABC News' Dr. Darien Sutton discusses ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

GLP-1 drugs like Wegovy and Ozempic are designed to treat type 2 diabetes, but are widely known for their effect on weight ...

GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment. Now new research out of ...

Weight-loss medications and bariatric surgery have both been found effective at helping people shed excess pounds — and now a new study ... who had obesity and diabetes, with no history of ...

Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes ... are highly effective at inducing weight loss, and most Americans are overweight ...

Popular weight ... diabetes and weight loss rose from 178,000 in 2022 to 480,000 in 2023. In 2023, the latest year for which data is available, Medi-Cal spent about $733 million on both drugs.

Popular weight ... diabetes and weight loss rose from 178,000 in 2022 to 480,000 in 2023. In 2023, the latest year for which data is available, Medi-Cal spent about $733 million on both drugs.

Popular drugs for weight loss are now being prescribed to kids as young as 12. It’s been nearly two years since the FDA approved their use in kids, but some are questioning if these drugs are ...